197 related articles for article (PubMed ID: 9042608)
1. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 and vascular smooth muscle cell proliferation.
Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H
Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
[TBL] [Abstract][Full Text] [Related]
3. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
5. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase.
Morinelli TA; Zhang LM; Newman WH; Meier KE
J Biol Chem; 1994 Feb; 269(8):5693-8. PubMed ID: 8119906
[TBL] [Abstract][Full Text] [Related]
7. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
Williams SP; Dorn GW; Rapoport RM
Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
[TBL] [Abstract][Full Text] [Related]
9. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
10. TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons.
Hsu KS; Huang CC; Kan WM; Gean PW
Am J Physiol; 1996 Oct; 271(4 Pt 1):C1269-77. PubMed ID: 8897834
[TBL] [Abstract][Full Text] [Related]
11. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Circulation; 1998 Feb; 97(6):589-95. PubMed ID: 9494030
[TBL] [Abstract][Full Text] [Related]
13. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
14. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
Jones DA; Benjamin CW; Linseman DA
Mol Pharmacol; 1995 Nov; 48(5):890-6. PubMed ID: 7476920
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta.
Craven PA; Studer RK; DeRubertis FR
Hypertension; 1996 Aug; 28(2):169-76. PubMed ID: 8707377
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
19. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
20. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]